Rockwell Medical Inc (RMTI) gains 2.66% for July 21

Equities Staff  |

Rockwell Medical Inc (NASDAQ: RMTI) shares gained 2.66%, or $0.0205 per share, to close Wednesday at $0.79. After opening the day at $0.76, shares of Rockwell Medical fluctuated between $0.81 and $0.76. 456,958 shares traded hands a decrease from their 30 day average of 1,445,168. Wednesday's activity brought Rockwell Medical’s market cap to $74,013,512.

Rockwell Medical is headquartered in Wixom, Michigan..

About Rockwell Medical Inc

Rockwell Medical is a biopharmaceutical company dedicated to transforming anemia management in a wide variety of therapeutic areas and across the globe, improving the lives of very sick patients. The Company's initial focus is the treatment of anemia in end-stage kidney disease (ESKD). Rockwell Medical's exclusive renal drug therapies, Triferic (ferric pyrophosphate citrate) Dialysate and Triferic AVNU (ferric pyrophosphate citrate injection), are the only FDA-approved therapeutics indicated for iron replacement and maintenance of hemoglobin in hemodialysis patients. Rockwell Medical is also an established manufacturer, supplier and leader in delivering high-quality hemodialysis concentrates/dialysates to dialysis providers and distributors in the U.S. and abroad.

Visit Rockwell Medical Inc’s profile for more information.

About The Nasdaq Stock Market

The Nasdaq Stock Market is a global leader in trading data and services, and equities and options listing. Nasdaq is the world's leading exchange for options volume and is home to the five largest US companies - Apple, Microsoft, Amazon, Alphabet and Facebook.

To get more information on Rockwell Medical Inc and to follow the company’s latest updates, you can visit the company’s profile page here: Rockwell Medical Inc’s Profile. For more news on the financial markets be sure to visit Equities News. Also, don’t forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Chart is provided by TradingView based on 15-minute-delayed prices. All other data is provided by IEX Cloud as of 8:05 pm ET on the day of publication.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Market Movers

Sponsored Financial Content